Found 53 matching trials
Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT) PHASE2 The PUMP-IT study is designed to prove the feasibility of HAIP chemotherapy...
Show More Location
Antoni van Leeuwenhoek (NKI-AVL)
Learn More & Join Trial
HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT) PHASE2 Patients with intrahepatic cholangiocarcinoma (IHC) have relatively aggress...
Show More Location
Oslo University Hospital
Learn More & Join Trial
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases PHASE2 Approximately 40% of colorectal cancer patients will develop colorectal liv...
Show More Location
Severance Hospital, Yonsei University Health System
Learn More & Join Trial
Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis PHASE4 Portal vein tumor invasion (PVT) is a common complication in HCC. the study...
Show More Location
Multiple Locations
Learn More & Join Trial
Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure PHASE2 Standard treatment of metastatic colorectal cancers relies on fluoropyrimid...
Show More Location
Centre Georges François Leclerc
Learn More & Join Trial
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria PHASE3 The purpose of this study is to evaluate the efficacy and safety of resecti...
Show More Location
Dongguan People's Hospital
Learn More & Join Trial
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT PHASE2 This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma NA This study intends to evaluate the efficacy and safety of drug-eluting tran...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy PHASE2 The purpose of the study is to assessed the efficiency of treatment based o...
Show More Location
Institut Gustave Roussy
Learn More & Join Trial
HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC PHASE3 The purpose of this study is to evaluate the efficacy and safety of hepatic...
Show More Location
Dongguan People's Hospital
Learn More & Join Trial